Hutchmed cashes in a Chinese JV to help fund its pipeline

Hutchmed has agreed to divest its share of a non-core Chinese JV through a pair of deals that will give it a cash injection to plough into R&D.

Boehringer takes on antimicrobial resistance with Evotec, bi...

A Franco-German joint venture company – Aurobac Therapeutics – has been formed to try to tackle the rising threat of antimicrobial resistant (AMR) infections.

Vifor joins forces with Evotec on kidney disease joint ventu...

Sanofi Pasteur and MSD end vaccines joint venture

Companies end collaboration after more than 20 years.